{"denoms":[{"counts":[{"groupId":"BG000","value":"123"},{"groupId":"BG001","value":"246"},{"groupId":"BG002","value":"369"}],"units":"Participants"}],"groups":[{"description":"Matching placebo tablets administered orally once daily for a duration until participants experienced disease progression, death, unacceptable toxicity, or participants withdrew consent","id":"BG000","title":"Placebo"},{"description":"Pazopanib 200 milligrams (mg) and 400 mg film-coated tablets (containing pazopanib monohydrochloride) administered orally at a dose of 800 mg once daily for a duration until participants experienced disease progression, death, unacceptable toxicity, or participants withdrew consent","id":"BG001","title":"Pazopanib"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"13.77","value":"51.7"},{"groupId":"BG001","spread":"14.92","value":"54.0"},{"groupId":"BG002","spread":"14.57","value":"53.2"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age Continuous","unitOfMeasure":"Years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"69"},{"groupId":"BG001","value":"147"},{"groupId":"BG002","value":"216"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"99"},{"groupId":"BG002","value":"153"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"6"}]}],"title":"African American/African Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}]}],"title":"American Indian or Alaska Native"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}]}],"title":"Asian - Central/South Asian Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"31"}]}],"title":"Asian - East Asian Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"31"},{"groupId":"BG002","value":"47"}]}],"title":"Asian - Japanese Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"}]}],"title":"Asian - South East Asian Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"}]}],"title":"White - Arabic/North African Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"89"},{"groupId":"BG001","value":"174"},{"groupId":"BG002","value":"263"}]}],"title":"White - White/Caucasian/European Heritage"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"}]}],"title":"Mixed Race"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"11"}]}],"title":"Unknown"}],"paramType":"NUMBER","title":"Race/Ethnicity, Customized","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"109"},{"groupId":"BG002","value":"158"}]}],"title":"Leiomyosarcoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"25"},{"groupId":"BG002","value":"38"}]}],"title":"Synovial sarcoma"},{"categories":[{"measurements":[{"groupId":"BG000","value":"61"},{"groupId":"BG001","value":"112"},{"groupId":"BG002","value":"173"}]}],"title":"Other STS histologies"}],"description":"Participants were categorized in the following histology subgroups of STS (as per the World Health Organization \\[WHO\\] classification, 2008): leiomyosarcoma, defined as malignant cancer of smooth muscle; synovial sarcoma, defined as cancer near the joints of the arm or leg; and other STS, defined as sarcoma without the tumor type of leiomyosarcoma or synovial sarcoma.","paramType":"NUMBER","title":"Number of participants in the indicated soft tissue sarcoma (STS) subgroups at Baseline","unitOfMeasure":"participants"}]}